Susceptibility to exacerbation in chronic obstructive pulmonary disease

Area of Science:

• Pulmonary Medicine
• Respiratory Disease Research
• Clinical Epidemiology

Background:

• Exacerbations are critical events in chronic obstructive pulmonary disease (COPD), yet their frequency, triggers, and impact remain incompletely understood.
• This study investigated a hypothesis of a frequent-exacerbation phenotype in COPD, distinct from overall disease severity.

Purpose of the Study:

• To identify and characterize a frequent-exacerbation phenotype in COPD patients.
• To determine if this phenotype is independent of disease severity (GOLD stages).
• To explore predictors and associated factors of the frequent-exacerbation phenotype.

Main Methods:

• Analysis of exacerbation frequency and associations in 2138 patients from the ECLIPSE study over 3 years.
• Exacerbations defined by antibiotic/corticosteroid prescription or hospitalization.
• Utilized Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging.

Main Results:

• Exacerbation frequency and severity increased with COPD progression (GOLD stages 2-4).
• A frequent-exacerbation phenotype (≥2 exacerbations/year) was observed in 22-47% of patients across GOLD stages.
• Prior exacerbations were the strongest predictor; the phenotype was also linked to gastroesophageal reflux, poorer quality of life, and elevated white blood cell count.

Conclusions:

• A distinct frequent-exacerbation phenotype in COPD exists, seemingly independent of disease severity.
• This phenotype is relatively stable and predictable, with implications for targeted exacerbation prevention strategies.
• Understanding this phenotype can guide interventions across the full spectrum of COPD severity.